SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Trinity Biotech (TRIBY) -- Ignore unavailable to you. Want to Upgrade?


To: dowman who wrote (9940)8/1/1998 11:29:00 PM
From: Scott H. Davis  Read Replies (2) | Respond to of 14328
 
Dowman, I'm with you part way on this one, but the tendancy may be over-applied in this case. Wise analysts and investors discount EPS for a company that has been recently profitible where some of their EPS comes from applying tax credits from earlier losses, knowing the credits are inflating earnings & won't last. If TRIBY is applying tax credits, than you have a point. But if TRIBYs EPS is all from revenue and the tax situation is not likely to change in the near/intermediate
future, I'm not too sure most will make an adjustment in this case. IMSCo Scott